PUBM · PubMatic, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on PUBM. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About PUBM · PubMatic, Inc.
PubMatic, Inc., a technology company, engages in the provision of a cloud infrastructure platform that enables real time programmatic advertising transactions for digital content creators, advertisers, agencies, agency trading desks, and demand side platforms worldwide. Its PubMatic SSP, a sell side platform for the purchase and sale of digital advertising inventory for publishers and buyers. The company also provides OpenWrap, a header bidding solution; Connect, a solution that provides additional data and insights to publishers and buyers; Activate, which allows buyers to execute direct deals on its platform across publisher inventory; Convert, a commerce media solution; and Identity Hub, an ID management tool for publishers that leverages specialized technology infrastructure to simplify alternative identifier marketplace. Its platform supports an array of ad formats and digital device types, including mobile app, mobile web, desktop, display, video, over the top video, connected television, and media. The company was incorporated in 2006 and is based in Redwood City, California.
Live Quote
HOLD (score +0) · 12-1 mom -11.1% · RSI 58.2 · above_both · -15.8% from high
Targets blend Wall Street consensus (9 analysts: low $8.00 / mean $12.89 / high $21.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Investigated PUBM following a Form 4 cluster trigger. The four June 2 filings are director RSU grants (code A = derivative acquisition at $0 strike), not open-market purchases — no cash outlay by insiders and therefore not genuine conviction signals under the methodology. CEO Rajeev Goel's May 27 filing shows options exercise (Class B→A conversion) followed immediately by a sale of 44,000 shares via a pre-existing 10b5-1 plan adopted March 2, 2025 — scheduled selling, not opportunistic buying. Q1 results were solid with revenue beating and Q2 guidance above consensus (+3.2% vs estimates), which explains the +44% YTD run. However, the stock is now at a forward P/E of ~24.7x with -2% YoY revenue decline and near-zero EBITDA margin, sitting only 13% below its 52-week high. The recent price appreciation appears fully explained by the earnings beat; no material mispricing or edge exists.